October 7, 2016 / 5:42 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Gap, Honeywell, Tyson Foods

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stocks fell on Friday after weaker-than-expected September jobs report had little effect on the prospects of an interest rate hike by the year end.

The Dow Jones Industrial Average was down 0.22 percent at 18,228.58, the S&P 500 was down 0.39 percent at 2,152.35 and the Nasdaq Composite was down 0.65 percent to 5,272.22.

** GAP INC, $26.135, +14.73 pct

The Banana Republic and Old Navy owner reported a lower-than-expected fall in comparable sales for September, helped by higher demand for its Old Navy Global brand.

** HONEYWELL INTERNATIONAL INC, $105.87, -8.42 pct

The aero parts supplier trimmed the upper end of its sales and profit forecast for the year.

** TYSON FOODS INC, $67.88, -8.74 pct

Brokerage Pivotal Research downgraded the U.S. meat processor’s stock to “sell” from “buy” and also cut its price target.

** PPG INDUSTRIES INC, $93.07, -8.92 pct

The chemical company said it expected to post a loss in the third quarter on charges related to a pension settlement.

** RUBY TUESDAY INC, $2.22, -11.55 pct

The restaurant chain operator’s first-quarter net loss widened and said it would stop giving forecast.

** LIPOCINE INC, Thursday close $4.17, +27.82 pct premarket

Brokerage H.C. Wainwright began coverage of the specialty pharmaceutical company’s stock with a “buy” rating and $25 price target.

** SAREPTA THERAPEUTICS INC, Thursday close $61.74, -7.76 pct premarket

Health insurer Anthem Inc said it would not cover the first U.S. Food and Drug Administration-approved Duchenne muscular dystrophy (DMD) drug, developed by Sarepta Therapeutics, calling it “investigational and not medically necessary”.

** CLOVIS ONCOLOGY INC, Thursday close $35.77, -15.49 pct premarket

All 377 ovarian cancer patients treated with 600 mg dose of company’s experimental drug, rucaparib, experienced adverse events, while 61 pct showed serious side-effects, the company said, citing safety data.

** CIDARA THERAPEUTICS INC, Thursday close $11.29, -10.63 pct premarket

The biotechnology company priced its public offering of 2.5 million shares at $10.10 per share, a 10.5 percent discount to the stock’s Thursday close.

** CAMPING WORLD HOLDINGS, $23.01, +4.59 pct

The RV and camping gear retailer’s stock opened 8 percent above its $22 IPO price on its first trading day and climbed to a session high of $24.35.

** SOLAREDGE TECHNOLOGIES INC, Thursday close $17.22, -9.58 pct premarket

** FIRST SOLAR INC, Thursday close $39.75, -5.56 pct premarket

Goldman Sachs downgraded Solaredge’s stock to “sell” from “neutral” and First Solar’s to “neutral” from “buy”.

** CIT GROUP INC, $36.93, +1.46 pct

Avolon Holdings Ltd, part of China’s acquisitive HNA Group, said it agreed to buy the company’s $10 billion aircraft leasing business.

** CARNIVAL CORP, $47.85, -2.01 pct

Hurricane Matthew, the first major hurricane threatening a direct hit on the United States in more than 10 years, hit Florida, threatening travel.

** NEPTUNE TECHNOLOGIES & BIORESSOURCES INC, Thursday close $1.38, +2.83 pct premarket

The nutrition products company’s unit signed an exclusive, worldwide and royalty bearing commercial agreement with Ingenutra Inc for its patented and clinically studied Maxsimil specialty ingredient.

** IDERA PHARMACEUTICALS INC, Thursday close $2.18, -13.07 pct premarket

The drug developer’s 25 million share offering was priced at $2.00 each.

** MISTRAS GROUP INC, Thursday close $23.33, -11.53 pct premarket

The testing services provider lowered its fiscal year 2017 revenue and earnings forecast as its expects continued weakness in revenue from the services segment.

** GW PHARMACEUTICALS, $131.246, -1.39 pct

Goldman Sachs initiated coverage of the drug developer’s stock with a “buy” rating.

** ACACIA COMMUNICATIONS INC, $102.685, -6.16 pct

The optical network company said its 4.5 million shares were priced at $100 in its first stock offering as a public company, an 8.6 percent discount to the stock’s Thursday close.


The oil and gas producer said it had received two proposals for its Gabon oil and gas interests and that it was in talks with the potential buyers.

** ORION GROUP HOLDINGS INC, $7.4, +4.37 pct

FBR & Co upgraded the construction company’s stock to “outperform” from “market perform” and raised its price target.

** LSB INDUSTRIES INC, $6.69, -7.21 pct

The chemical and climate control products maker said turnaround activities and various operational issues resulted in unplanned downtime at three primary chemical facilities in the quarter, impacting its EBITDA. (Compiled by Nikhil Subba in Bengaluru; Editing by Anil D’Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below